Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cncr.31801 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure-Authors' Reply.
Aliment Pharmacol Ther
December 2024
Department of Medical Sciences, Liver Unit, University of Turin, Turin, Italy.
Letter in reply: Timing of venous thromboembolism prophylaxis initiation and complications in polytrauma patients with high-risk bleeding orthopedic interventions: A nationwide analysis.
J Trauma Acute Care Surg
December 2024
Department of Surgery, Avedisian School of Medicine, Boston University Chobanian, Boston, MA
Reply to Teng et al. Comment on "Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. 2024, , 3190".
J Clin Med
November 2024
Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
We would like to express our sincere gratitude for your thoughtful review of our article [...
View Article and Find Full Text PDFReply to: Short-term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al.
Arthritis Rheumatol
December 2024
Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK.
The potential impact of educational attainment on NAFLD risk. Author's reply.
Eur J Intern Med
December 2024
First Department of Medicine, University Clinic Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria; Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria; Department of Internal Medicine, Saint John of God Hospital, Teaching Hospital of the Paracelsus Medical Private University, Salzburg, Austria. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!